UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000042311
Receipt No. R000048230
Scientific Title The Effect of Virtual Reality on Derilium of trauma patients in Intensive Care Unit.
Date of disclosure of the study information 2020/11/01
Last modified on 2020/11/01 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The Effect of Virtual Reality on Derilium of trauma patients in Intensive Care Unit.
Acronym The Effect of Virtual Reality on Derilium of trauma patients in Intensive Care Unit.
Scientific Title The Effect of Virtual Reality on Derilium of trauma patients in Intensive Care Unit.
Scientific Title:Acronym The Effect of Virtual Reality on Derilium of trauma patients in Intensive Care Unit.
Region
Japan

Condition
Condition trauma patients
Classification by specialty
Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The effect of virtual reality on Delirium of trauma patients in Intensive Care Unit .
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Intensive Care Delirium Screening Checklist score
CAM-ICU
Key secondary outcomes mortality rate ,vital sign , APACHE2 and SOFA
pharmacy ,level of consciousness
RASS scale , Visual analog scale
the balance between sympathetic nerve with parasympathetic nerve , three month after ICU discharge

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 using Virtual Reality twice away for about one week.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria above 20 years old trauma patients in ICU can confirm

Key exclusion criteria patients can watch
patients can hear
no face trauma
claustrophobia and acrofobia
seizure
VR sinckness
Target sample size 220

Research contact person
Name of lead principal investigator
1st name Motomu
Middle name
Last name Shimaoka
Organization Mie University Graduate School of Medicine
Division name Dept of Molecular Pathobiology and Cell Adhesion Biology
Zip code 514-8507
Address 2-174 Edobashi Tsu-City
TEL 0592315036
Email motomushimaoka@gmail.com

Public contact
Name of contact person
1st name Eiji
Middle name
Last name Kawamoto
Organization Mie University Graduate School of Medicine
Division name Emergency and Disaster Medicine
Zip code 514-8507
Address 2-174 Edobashi Tsu-City
TEL 059-232-1111
Homepage URL
Email a-2kawamoto@clin.medic.mie-u.ac.jp

Sponsor
Institute Mie University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Mie University hospital
Address Edobashi Tsu-city
Tel 0592321111
Email kk-sien@mo.medic.mie-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 11 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 10 Month 30 Day
Date of IRB
Anticipated trial start date
2020 Year 10 Month 30 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 11 Month 01 Day
Last modified on
2020 Year 11 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048230